Provention Bio Inc
NASDAQ:PRVB
Income Statement
Earnings Waterfall
Provention Bio Inc
Revenue
|
12.9m
USD
|
Cost of Revenue
|
-2.6m
USD
|
Gross Profit
|
10.3m
USD
|
Operating Expenses
|
-138.5m
USD
|
Operating Income
|
-128.2m
USD
|
Other Expenses
|
14.6m
USD
|
Net Income
|
-113.6m
USD
|
Income Statement
Provention Bio Inc
Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
1
+106%
|
2
+42%
|
3
+38%
|
3
+3%
|
13
+361%
|
|
Gross Profit | ||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
10
N/A
|
|
Operating Income | ||||||||||||||||||||||
Operating Expenses |
(9)
|
(14)
|
(20)
|
(24)
|
(27)
|
(33)
|
(35)
|
(40)
|
(44)
|
(46)
|
(57)
|
(78)
|
(100)
|
(119)
|
(127)
|
(123)
|
(117)
|
(114)
|
(115)
|
(117)
|
(141)
|
|
Selling, General & Administrative |
(1)
|
(2)
|
(3)
|
(4)
|
(4)
|
(5)
|
(5)
|
(7)
|
(8)
|
(11)
|
(17)
|
(24)
|
(33)
|
(42)
|
(48)
|
(48)
|
(47)
|
(47)
|
(48)
|
(51)
|
(64)
|
|
Research & Development |
(8)
|
(12)
|
(18)
|
(21)
|
(23)
|
(28)
|
(30)
|
(33)
|
(36)
|
(35)
|
(40)
|
(54)
|
(66)
|
(77)
|
(79)
|
(75)
|
(70)
|
(67)
|
(67)
|
(66)
|
(76)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
|
Operating Income |
(9)
N/A
|
(14)
-55%
|
(20)
-44%
|
(24)
-20%
|
(27)
-10%
|
(33)
-23%
|
(35)
-6%
|
(40)
-13%
|
(44)
-12%
|
(46)
-4%
|
(57)
-23%
|
(78)
-38%
|
(100)
-28%
|
(119)
-20%
|
(127)
-6%
|
(122)
+3%
|
(116)
+6%
|
(112)
+3%
|
(112)
+0%
|
(114)
-2%
|
(128)
-13%
|
|
Pre-Tax Income | ||||||||||||||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
Total Other Income |
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(9)
N/A
|
(14)
-55%
|
(20)
-45%
|
(24)
-20%
|
(27)
-9%
|
(33)
-22%
|
(34)
-5%
|
(39)
-13%
|
(43)
-12%
|
(45)
-4%
|
(56)
-24%
|
(77)
-39%
|
(99)
-29%
|
(119)
-20%
|
(126)
-6%
|
(122)
+3%
|
(115)
+6%
|
(112)
+3%
|
(112)
+0%
|
(113)
-1%
|
(127)
-12%
|
|
Net Income | ||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
8
|
7
|
7
|
13
|
|
Income from Continuing Operations |
(9)
|
(14)
|
(20)
|
(24)
|
(26)
|
(32)
|
(34)
|
(38)
|
(43)
|
(45)
|
(55)
|
(77)
|
(99)
|
(118)
|
(125)
|
(121)
|
(114)
|
(104)
|
(105)
|
(106)
|
(114)
|
|
Net Income (Common) |
(9)
N/A
|
(15)
-54%
|
(21)
-43%
|
(25)
-19%
|
(27)
-8%
|
(33)
-22%
|
(34)
-5%
|
(38)
-13%
|
(43)
-13%
|
(45)
-4%
|
(55)
-23%
|
(77)
-39%
|
(99)
-29%
|
(118)
-20%
|
(125)
-6%
|
(121)
+3%
|
(114)
+6%
|
(104)
+9%
|
(105)
-1%
|
(106)
-2%
|
(114)
-7%
|
|
EPS (Diluted) |
-0.27
N/A
|
-0.42
-56%
|
-0.61
-45%
|
-0.73
-20%
|
-0.79
-8%
|
-0.87
-10%
|
-0.91
-5%
|
-0.94
-3%
|
-0.9
+4%
|
-0.94
-4%
|
-1.11
-18%
|
-1.35
-22%
|
-1.74
-29%
|
-1.9
-9%
|
-1.97
-4%
|
-1.91
+3%
|
-1.81
+5%
|
-1.64
+9%
|
-1.61
+2%
|
-1.27
+21%
|
-1.29
-2%
|